Spotlight
A selection of resources from across the Federation
HIV Theory of Change
Our HIV Theory of Change is to clarify the goals and vision of IPPF’s HIV programme and to articulate the different pathways and strategies IPPF uses to contribute towards its HIV goals and vision.
Filter our resources by:
| 06 December 2019
IMAP statement on expanding access and contraceptive choice through integrated sexual and reproductive health services
In 2018, IPPF endorsed the WHO/UNFPA Call to Action to Attain Universal Health Coverage Through Linked Sexual and Reproductive Health and Rights and HIV Interventions.13 This IMAP statement serves as a reminder of this call to action to ensure all people have access to comprehensive SRH services, including integrated contraceptive and HIV/STI services, provided through primary healthcare.
| 28 October 2019
After the ECHO trial – Expanding access and choice through integrated services
Since the early 1990s, the evidence has been inconclusive as to whether using hormonal contraception increases women’s risk of acquiring HIV, particularly among progestogen-only injectable users. Observational studies indicated that women using progestogen-only injectable contraceptive methods may be at higher risk of acquiring human immunodeficiency virus (HIV). The Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial finds no link between HIV acquisition and the use of DMPA-IM, progestogen implant, and non-hormonal copper IUD. For more information please see the technical brief on the ECHO trial. Following the release of the result of the ECHO trial and the WHO latest guidance statement and revised Medical Eligibility Criteria (MEC) for contraceptive use, IPPF developed a follow-up technical brief to support IPPF MAs and frontline service providers’ work regarding the provision of the integrated contraceptive, HIV and other STI programmes to expand access and contraceptive choice. For more information, please see the attached technical brief After the ECHO trial – Expanding access and choice through integrated services, available in English and French.
| 09 July 2019
IPPF Technical Brief on the ECHO trial
Since the early 1990s, the evidence has been inconclusive as to whether using hormonal contraception increases women’s risk of acquiring HIV, particularly among progestogen-only injectable users. Observational studies indicated that women using progestogen-only injectable contraceptive methods may be at higher risk of acquiring human immunodeficiency virus (HIV). The ECHO trial finds no link between HIV acquisition and the use of DMPA-IM, progestogen implant, and non-hormonal copper IUD.
| 24 May 2019
The Period Quiz
The Period QuizAbout half the world’s population menstruates at some point in their lives, but periods are still a big taboo in many places. What do you really know about the flow? Find out in our quiz...How many periods does the average person have in a lifetime?Only girls and women get periodsAt what point during the menstrual cycle is someone most likely to get pregnant?How much blood does the average person lose during a period?What proportion of girls in Ghana sometimes miss school due to their periods?What is the lifetime cost of a period in the UK?How many menstruators in India use unsafe materials (such as ashes and mud) to manage their periods?Good try! ? If you learned something new today, scroll down to share this with friends.Great work! ? If you learned something new today, scroll down to share this with friends.
| 17 May 2018
Watch: Hope on the Horizon: FGM in Somaliland
Female genital mutilation (FGM) is a procedure that involves altering or injuring female genitalia for non-medical reasons. It is estimated that almost 200 million women and girls worldwide have undergone some form of FGM. FGM has been recorded in 30 countries with Somaliland having one of the highest prevalence rates in the world at 98% for women and girls aged between 15 - 49 years old. Hope on the horizon documents the hard work IPPF member association SOFHA (Somaliland Family Health Association) is doing within the local community to help change minds and eventually bring an end to female genital mutilation (FGM). Slowly, but surely, attitudes are changing.
| 15 March 2018
Integration of DMPA‑SC into the method mix contributes to increased uptake of all methods of family planning
Injectable contraceptives are an increasingly popular method of family planning. They are safe, discrete, highly effective, and generally last for several months. Sayana® Press, also known as subcutaneous depot medroxyprogesterone (DMPA‑SC), is a lower‑dose formula version of the already popular injectable Depo‑Provera. DMPA‑SC combines the drug and needle in a single‑use unit, which makes it easy to transport and simple to use with little training. DMPA‑SC can be administered by community health workers (CHWs) and women themselves – potentially making injectable contraceptives available to women who can’t easily travel to clinics.